KHK-IN-5
KHK-IN-5 (Compound 18) is a KHK inhibitor. KHK-IN-5 can be used for the research of nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and type 2 diabetes (T2DM) [1].
Product Specifications
CAS Number
3043939-40-5
UNSPSC
12352005
Target
Ketohexokinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/khk-in-5.html
Smiles
N#CC(C(C(F)F)=CC(N1C[C@@]2([H])[C@@](CNC2)([H])C1)=N3)=C3NC4=C(C=CC=C4)SC
Molecular Formula
C20H21F2N5S
Molecular Weight
401.48
References & Citations
[1]Sabnis RW. Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II Diabetes. ACS Med Chem Lett. 2024 Jul 23;15 (8) :1191-1192.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL511988V 500 µL Each
Gpr182 Mouse shRNA Lentiviral Particle (Locus ID 11536)
Sign In for Pricing
View Details 374340-01 20 µg
MYCN, Recombinant, Human, aa1-464, His-Tag (N-myc Proto-oncogene Protein)
Sign In for Pricing
View Details 374340-02 100 µg
MYCN, Recombinant, Human, aa1-464, His-Tag (N-myc Proto-oncogene Protein)
Sign In for Pricing
View Details 